levonorgestrel has been researched along with Vascular Diseases in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
De Martino, M; Govind, A | 1 |
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
Rozenbaum, H | 1 |
Abed, A; Chelli, H; Habibi, H; Khrouf, M; Messaad, J; Ouerghemmi, R; Rouis, M; Sfar, E; Zouari, F | 1 |
Maclennan, AH | 1 |
Ishak, R | 1 |
Ahmad, R; Ang, ES; Gudum, HR; Hassan, K; Ishak, R | 1 |
Kaplan, PF; Meendering, JR; Minson, CT; Torgrimson, BN | 1 |
Dwarte, D; Fraser, IS; Hickey, M | 1 |
1 trial(s) available for levonorgestrel and Vascular Diseases
Article | Year |
---|---|
Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
Topics: Adult; Blood Pressure; Brachial Artery; Contraceptives, Oral, Combined; Drug Administration Schedule; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Heart Rate; Humans; Levonorgestrel; Nitroglycerin; Progestins; Reference Values; Risk Assessment; Vascular Diseases; Vasodilation; Vasodilator Agents | 2007 |
10 other study(ies) available for levonorgestrel and Vascular Diseases
Article | Year |
---|---|
SCAD: a gendered cardiac threat.
Topics: Adult; Clomiphene; Contraception; Contraceptives, Oral; Coronary Vessel Anomalies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Vascular Diseases | 2020 |
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |
[Progestins and arterial disease].
Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases | 1985 |
[Norplant contraception at the Rabta Tunis maternity hospital].
Topics: Africa; Africa, Northern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Diabetes Mellitus; Disease; Family Planning Services; Heart Diseases; Hypertension; Lactation; Levonorgestrel; Menstruation Disturbances; Middle East; Physiology; Pregnancy; Prospective Studies; Research; Risk Factors; Tunisia; Vascular Diseases | 1994 |
Oral contraceptives.
Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases | 1987 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
Fibrinolytic response in women on low-dose oral contraceptive.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developing Countries; Diagnosis; Disease; Embolism; Family Planning Services; Fibrinolysis; Hematologic Tests; Levonorgestrel; Malaysia; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases | 1992 |
Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Menstruation; Ovulation; Prospective Studies; Uterine Hemorrhage; Vascular Diseases | 2000 |